Latest Breaking News On - Ongoing business development - Page 1 : comparemela.com

AIM ImmunoTech Outlines Recent Progress Across Clinical Development Pipeline and Provides Business Update

AIM ImmunoTech Outlines Recent Progress Across Clinical Development Pipeline and Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesThomask equelsExchange commissionOngoing business developmentImmunotech incExecutive officer thomasRecurrent ovarian cancerAdvanced pancreatic adenocarcinomaPrivate securities litigation reform act

AIM ImmunoTech Inc : AIM ImmunoTech Outlines Recent Progress Across Clinical Development Pipeline and Provides Business Update

AIM ImmunoTech Inc : AIM ImmunoTech Outlines Recent Progress Across Clinical Development Pipeline and Provides Business Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesThomask equelsErasmus medical centerImmunotech incExchange commissionOngoing business developmentExecutive officer thomasRecurrent ovarian cancerAdvanced pancreatic adenocarcinomaPrivate securities litigation reform act

NLS Pharmaceutics CEO Issues Letter to Shareholders

ZURICH, SWITZERLAND / ACCESSWIRE / December 29, 2023 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company, focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system.

United statesUnited kingdomFrance generalElena thyen pighinMarianne lambertsonAllouch akninFlorence allouche akninClaudio bassettiClaudio la bassettiAlex zwyerAllouche akninEuropean neurological societyNeurology departmentAexon lab dual orexin receptor agonistsAmerican academy of sleep medicineOngoing business development

NLS Pharmaceutics, Whose Narcolepsy Drug Candidate Is In Clinical Trials, Recaps 2023

In a letter to shareholders, the CEO of NLS Pharmaceutics Ltd recapped the company’s progress and pitfalls for 2023.

Alex zwyerPharmaceutics ltdOngoing business developmentAexon labAexon labs incResearch societySleep research societyAexon labsKleine levin syndrome

NLS Pharmaceutics (NLSP) CEO Issues Letter to Shareholders

NLS Pharmaceutics (NLSP) CEO Issues Letter to Shareholders
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomFrance generalElena thyen pighinClaudio la bassettiAlex zwyerAllouche akninFlorence allouche akninAllouch akninClaudio bassettiAexon labs incEuropean sleep research societyEuropean academy of neurologyAexon lab dual orexin receptor agonistsCaligor coghlan pharma servicesResearch society